We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+16.08%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$232M
AUM Growth
-$281M
(-55%)
Cap. Flow
-$304M
Cap. Flow
% of AUM
-130.94%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
133
New
10
Increased
39
Reduced
47
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
argenx
ARGX
|
+$4.1M |
| 2 |
SLRN
ACELYRIN
SLRN
|
+$2.78M |
| 3 |
Merck
MRK
|
+$2.54M |
| 4 |
Edgewise Therapeutics
EWTX
|
+$2.3M |
| 5 |
Travere Therapeutics
TVTX
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$11.2M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$10.6M |
| 3 |
HealthEquity
HQY
|
+$10.5M |
| 4 |
Evolent Health
EVH
|
+$10.4M |
| 5 |
RadNet
RDNT
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.21% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Structure Therapeutics
GPCR
$3.44B
| $139K | 0.06% |
+3,400
| New | +$195K |
|
102
Zentalis Pharmaceuticals
ZNTL
$331M
| $111K | 0.05% |
7,355
-379,170
| -98% | -$5.53M |
|
103
Zai Lab
ZLAB
$2.05B
| $109K | 0.05% |
4,000
+1,000
| +33% | +$26.4K |
|
104
Summit Therapeutics
SMMT
$10.4B
| $78.3K | 0.03% |
30,000
+10,000
| +50% | +$20.6K |
|
105
Arcutis Biotherapeutics
ARQT
$3.24B
| – | – |
-4,357
| Closed | -$23.1K |
|
106
Alphatec Holdings
ATEC
$1.56B
| – | – |
-246,345
| Closed | -$3.2M |
|
107
AtriCure
ATRC
$1.97B
| – | – |
-236,532
| Closed | -$10.4M |
|
108
Atea Pharmaceuticals
AVIR
$369M
| – | – |
-600,461
| Closed | -$1.8M |
|
109
DocGo
DCGO
$64M
| – | – |
-651,400
| Closed | -$3.47M |
|
|
110
Evolent Health
EVH
$353M
| – | – |
-383,142
| Closed | -$10.4M |
|
|
GBIO
111
DELISTED
Generation Bio
GBIO
| – | – |
-35,674
| Closed | -$1.35M |
|
112
Glaukos
GKOS
$10.1B
| – | – |
-69,000
| Closed | -$5.19M |
|
|
113
HealthEquity
HQY
$8.72B
| – | – |
-143,875
| Closed | -$10.5M |
|
114
iRhythm Holdings
IRTC
$4.1B
| – | – |
-33,000
| Closed | -$3.11M |
|
115
Lantheus
LNTH
$6.59B
| – | – |
-70,987
| Closed | -$4.93M |
|
116
MacroGenics
MGNX
$243M
| – | – |
-387,001
| Closed | -$1.8M |
|
117
Merit Medical Systems
MMSI
$5.11B
| – | – |
-79,000
| Closed | -$5.45M |
|
118
Ocular Therapeutix
OCUL
$1.84B
| – | – |
-969,350
| Closed | -$3.04M |
|
119
Progyny
PGNY
$2.47B
| – | – |
-120,000
| Closed | -$4.08M |
|
120
PTC Therapeutics
PTCT
$5.68B
| – | – |
-187,016
| Closed | -$4.19M |
|
|
121
RadNet
RDNT
$5.25B
| – | – |
-369,134
| Closed | -$10.4M |
|
122
Rallybio
RLYB
$84.6M
| – | – |
-46,995
| Closed | -$1.27M |
|
123
Scholar Rock
SRRK
$5.49B
| – | – |
-310,398
| Closed | -$2.2M |
|
124
STAAR Surgical
STAA
$1.21B
| – | – |
-47,000
| Closed | -$1.89M |
|
125
TELA Bio
TELA
$33.1M
| – | – |
-525,000
| Closed | -$4.2M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
TGM
BIS
Sectoral Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Sectoral Asset Management held 133 positions worth $232M, down 55% from $514M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Sectoral Asset Management withdrew a net $304M in Q4 2023, closing 29 positions and reducing 47 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in ACELYRIN worth $2.43M.
- Sectoral Asset Management's largest Q4 2023 buy was ACELYRIN: 325,549 shares worth $2.43M.
- Sectoral Asset Management added most to argenx in Q4 2023, an estimated $4.1M increase.
- Sectoral Asset Management's biggest Q4 2023 reduction was Blueprint Medicines, cutting an estimated $10.6M.
- Sectoral Asset Management fully exited R1 RCM Inc. Common Stock in Q4 2023, selling an estimated $11.2M.
- Sectoral Asset Management's ten largest holdings make up 35% of its $232M portfolio in Q4 2023.
- Sectoral Asset Management opened 10 new positions and closed 29 in Q4 2023.
- Sectoral Asset Management's portfolio value fell 55% quarter-over-quarter to $232M.
Based on Sectoral Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.